This Book >>

  • 334pp. Published March 2017
  • Scientific Research Publishing, Inc.,USA.
  • Category: Medicine & Healthcare
  • ISBN: 978-1-61896-322-2
  • (Hardcover) USD 109.00
  • ISBN: 978-1-61896-321-5
  • (Paperback) USD 89.00
Authors/Editors Price: 40% off
Buy at:

Connect with SCIRP >>

Home > Books > Advances in Colorectal Neoplasms
Advances in Colorectal Neoplasms
  • Description
  • Author(s) Information

Colorectal cancer (CRC), also known as bowel cancer, is the development of cancer from the colon or rectum (parts of the large intestine). It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time. Most colorectal cancers are due to old age and lifestyle factors with only a small number of cases due to underlying genetic disorders. Treatments used for colorectal cancer may include some combination of surgery, radiation therapy, chemotherapy and targeted therapy. Cancers that are confined within the wall of the colon may be curable with surgery while cancers that have spread widely are usually not curable, with management focusing on improving quality of life and symptoms. Globally, colorectal cancer is the third most common type of cancer making up about 10% of all cases. In 2012, there were 1.4 million new cases and 694,000 deaths from the disease.

In the present book, fifteen typical literatures about colorectal neoplasms published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, colorectal cancer, epidemiology, ect. We hope this book can demonstrate advances in colorectal neoplasms as well as give references to the researchers, students and other related people.
Components of the Book:
  • Chapter 1
    Lifestyle Modifications and Colorectal Cancer
  • Chapter 2
    Systematic Review: Brain Metastases from Colorectal Cancer—Incidence and Patient Characteristics
  • Chapter 3
    A Systematic Review of Special Events to Promote Breast, Cervical and Colorectal Cancer Screening in the United States
  • Chapter 4
    Positive Family History of Colorectal Cancer in a General Practice Setting [FRIDA.Frankfurt]: Study Protocol of a Cross-Sectional Study
  • Chapter 5
    The Association between Cecal Insertion Time and Colorectal Neoplasm Detection
  • Chapter 6
    Mutated In Colorectal Cancer (MCC) Is a Novel Oncogene in B Lymphocytes
  • Chapter 7
    Mutational Profiles of Different Macroscopic Subtypes of Colorectal Adenoma Reveal Distinct Pathogenetic Roles for KRAS, BRAF and PIK3CA
  • Chapter 8
    Over-Expression of COX-2 MRNA in Colorectal Cancer
  • Chapter 9
    ShaoYao Decoction Ameliorates Colitis-Associated Colorectal Cancer by Downregulating Proinflammatory Cytokines and Promoting Epithelial-Mesenchymal Transition
  • Chapter 10
    Shenling Baizhu San Supresses Colitis Associated Colorectal Cancer through Inhibition of Epithelialmesenchymal Transition and Myeloid-Derived Suppressor Infiltration
  • Chapter 11
    A Genome-Wide Systems Analysis Reveals Strong Link between Colorectal Cancer and Trimethylamine N-Oxide (TMAO), a Gut Microbial Metabolite of Dietary Meat and Fat
  • Chapter 12
    Blood RNA Biomarker Panel Detects Both Left- and Right-Sided Colorectal Neoplasms: A Case–Control Study
  • Chapter 13
    Evaluation of an Assay for Methylated BCAT1 and IKZF1 in Plasma for Detection of Colorectal Neoplasia
  • Chapter 14
    Association between Ischemic Heart Disease and Colorectal Neoplasm: A Systematic Review and Meta‑Analysis
  • Chapter 15
    Efficacy and Safety of Bevacizumab Plus Chemotherapy Compared to Chemotherapy Alone in Previously Untreated Advanced or Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
Readership: Students, academics, teachers and other people attending or interested in Colorectal Neoplasms.
comments powered by Disqus